Multiple classes of environmental chemicals are associated with liver disease: NHANES 2003-2004

International Journal of Hygiene and Environmental Health

Volumn 216, Issue 6, 2013, Pages 703-709

  Yorita Christensen, Krista L ^a   Carrico, Caroline K ^b   Sanyal, Arun J ^c   Gennings, Chris ^b  

^a U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^c VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

ALT; Biomonitoring; Cumulative; Liver; Mixtures

Indexed keywords

ALANINE AMINOTRANSFERASE; DIOXIN; HEAVY METAL; MERCURY; POLYCHLORINATED BIPHENYL;

ADOLESCENT; ADULT; AGED; ALT; ARTICLE; BIOLOGICAL MONITORING; BLOOD; CHILD; CUMULATIVE; DRUG EFFECT; ENVIRONMENTAL EXPOSURE; ENZYMOLOGY; FEMALE; HUMAN; LIVER; MALE; MIDDLE AGED; MIXTURES; NUTRITION; POLLUTANT; TOXIC HEPATITIS; YOUNG ADULT;

ALT; BIOMONITORING; CUMULATIVE; LIVER; MIXTURES;

ADOLESCENT; ADULT; AGED; ALANINE TRANSAMINASE; CHILD; DIOXINS; DRUG-INDUCED LIVER INJURY; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL POLLUTANTS; FEMALE; HUMANS; LIVER; MALE; MERCURY; METALS, HEAVY; MIDDLE AGED; NUTRITION SURVEYS; POLYCHLORINATED BIPHENYLS; YOUNG ADULT;

EID: 84884591541     PISSN: 14384639     EISSN: 1618131X     Source Type: Journal    
DOI: 10.1016/j.ijheh.2013.01.005     Document Type: Article

References (31)

1. Al-Attar A.M. Vitamin E attenuates liver injury induced by exposure to lead, mercury, cadmium and copper in albino mice. Saudi J. Biol. Sci. 2011, 18(4):395-401.
2. ATSDR Toxicological Profile for Mercury 1999, U.S. Department of Health and Human Services. Public Health Service, Agency for Toxic Substances and Disease Registry, Atlanta, GA, USA.
3. ATSDR Toxicological Profile for Polychlorinated Biphenyls (PCBs) 2000, U.S. Department of Health and Human Services. Public Health Service, Agency for Toxic Substances and Disease Registry, Atlanta, GA.
4. ATSDR Toxicological Profile for Cadmium 2008, U.S. Department of Health and Human Services. Public Health Service, Agency for Toxic Substances and Disease Registry, Atlanta, GA, USA.
5. Branco V., Canario J., Lu J., Holmgren A., Carvalho C. Mercury and selenium interaction in vivo: effects on thioredoxin reductase and glutathione peroxidase. Free Radic. Biol. Med. 2012, 52(4):781-793.
6. Branco V., Ramos P., Canario J., Lu J., Holmgren A., Carvalho C. Biomarkers of adverse response to mercury: histopathology versus thioredoxin reductase activity. J. Biomed. Biotechnol. 2012, 359879.
7. Browning J.D., Szczepaniak L.S., Dobbins R., Nuremberg P., Horton J.D., Cohen J.C., et al. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 2004, 40(6):1387-1395.
8. Cave M., Appana S., Patel M., Falkner K.C., McClain C.J., Brock G. Polychlorinated biphenyls, lead, and mercury are associated with liver disease in American adults: NHANES 2003-2004. Environ. Health Perspect. 2010, 118(12):1735-1742.
9. Centers for Disease Control and Prevention (CDC), National Center for Health Statistics (NCHS) National Health and Nutrition Examination Survey Data 2008, U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, 2003-2004, Hyattsville, MD.
10. CDC Fourth National Report on Human Exposure to Environmental Chemicals 2009, Department of Health and Human Services, Centers for Disease Control and Prevention, Atlanta, GA, USA.
11. Chisolm J.J. Lead poisoning. Sci. Am. 1971, 224(2):15-23.
12. Clark J.M., Brancati F.L., Diehl A.M. The prevalence and etiology of elevated aminotransferase levels in the United States. Am. J. Gastroenterol. 2003, 98(5):960-967.
13. Collison K.S., Saleh S.M., Bakheet R.H., Al-Rabiah R.K., Inglis A.L., Makhoul N.J., et al. Diabetes of the liver: the link between nonalcoholic fatty liver disease and HFCS-55. Obesity 2009, 17(11):2003-2013.
14. Cortez-Pinto H., Chatham J., Chacko V.P., Arnold C., Rashid A., Diehl A.M. Alterations in liver ATP homeostasis in human nonalcoholic steatohepatitis: a pilot study. JAMA 1999, 282(17):1659-1664.
15. Dufault R., LeBlanc B., Schnoll R., Cornett C., Schweitzer L., Wallinga D., et al. Mercury from chlor-alkali plants: measured concentrations in food product sugar. Environ. Health: Glob. Access Sci. Source 2009, 8:2.
16. Ekstedt M., Franzen L.E., Mathiesen U.L., Thorelius L., Holmqvist M., Bodemar G., et al. Long-term follow-up of patients with NAFLD and elevated liver enzymes. Hepatology 2006, 44(4):865-873.
17. EPA US Air Quality Criteria for Lead (2006) Final Report 2006, U.S. Environmental Protection Agency, Washington, DC.
18. Gennings C., Sabo R., Carney E. Identifying subsets of complex mixtures most associated with complex diseases polychlorinated biphenyls and endometriosis as a case study. Epidemiology 2010, 21:S77-S84.
19. Goncharov A., Pavuk M., Foushee H.R., Carpenter D.O. Blood pressure in relation to concentrations of PCB congeners and chlorinated pesticides. Environ. Health Perspect. 2011, 119(3):319-325.
20. Johnson B.L., Hicks H.E., Cibulas W., Faroon O., Ashizawa A.E., De Rosa C.T., et al. Public Health Implications of Exposure to Polychlorinated Biphenyls (PCBs) 2008, Agency for Toxic Substances and Disease Registry, Division of Toxicology and Environmental Medicine, Atlanta, GA, USA.
21. Kawasaki T., Igarashi K., Koeda T., Sugimoto K., Nakagawa K., Hayashi S., et al. Rats fed fructose-enriched diets have characteristics of nonalcoholic hepatic steatosis. J. Nutr. 2009, 139(11):2067-2071.
22. Kortenkamp A. Low dose mixture effects of endocrine disrupters: implications for risk assessment and epidemiology. Int. J. Androl. 2008, 31(2):233-237.
23. Marchesini G., Brizi M., Bianchi G., Tomassetti S., Bugianesi E., Lenzi M., et al. Nonalcoholic fatty liver disease - a feature of the metabolic syndrome. Diabetes 2001, 50(8):1844-1850.
24. Needleman H. Lead poisoning. Annu. Rev. Med. 2004, 55:209-222.
25. Patnaik B.B., Roy A., Agarwal S., Bhattacharya S. Induction of oxidative stress by non-lethal dose of mercury in rat liver: possible relationships between apoptosis and necrosis. J. Environ. Biol. 2010, 31(4):413-416.
26. Sanyal A.J., Campbell-Sargent C., Mirshahi F., Rizzo W.B., Contos M.J., Sterling R.K., et al. Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. Gastroenterology 2001, 120(5):1183-1192.
27. Schecter A., Cramer P., Boggess K., Stanley J., Papke O., Olson J., et al. Intake of dioxins and related compounds from food in the U.S. population. J. Toxicol. Environ. Health A 2001, 63(1):1-18.
28. Shen K., Shen C., Yu J., Yu C., Chen L., Shi D., et al. PCB congeners induced mitochondrial dysfunction in Vero cells. J. Hazard. Mater. 2011, 185(1):24-28.
29. Thornton J.W., McCally M., Houlihan J. Biomonitoring of industrial pollutants: health and policy implications of the chemical body burden. Public Health Rep. 2002, 117(4):315-323.
30. Wolff M.S., Camann D., Gammon M., Stellman S.D. Proposed PCB congener groupings for epidemiological studies. Environ. Health Perspect. 1997, 105(1):13-14.
31. Yamazaki K., Suzuki M., Itoh T., Yamamoto K., Kanemitsu M., Matsumura C., et al. Structural basis of species differences between human and experimental animal CYP1A1s in metabolism of 3,3',4,4',5-pentachlorobiphenyl. J. Biochem. 2011, 149(4):487-494.